ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2025

Obesity update: cardiovascular risk and therapeutic innovations (focus on semaglutide and tirzepatide).

Luca Antonio Felice Di Odoardo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.